Aug 12, 2025 · Idacio (adalimumab-aacf) is a biosimilar to Humira, it is used to treat chronic conditions, including rheumatoid arthritis, psoriasis, Crohn's disease, and more.

Jul 3, 2023 · Fresenius Kabi announced today the immediate availability in the U.S. of its citrate-free adalimumab biosimilar IDACIO® (adalimumab-aacf) for use in the treatment of chronic autoimmune …

Jan 15, 2025 · Idacio (Adalimumab-aacf Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …

This product is IDACIO® (adalimumab-aacf). IDACIO® (adalimumab-aacf) is biosimilar* to HUMIRA® (adalimumab). See full prescribing information for complete boxed warning.

Aug 5, 2025 · Patients treated with adalimumab products including IDACIO are at increased risk for developing serious infections that may lead to hospitalization or death [see Warnings and …

Apr 17, 2019 · Idacio is available as a solution for injection under the skin in a vial or pre-filled syringe or pen, and is usually given every 2 weeks. The dose and frequency of injection depend on the …

Nov 5, 2023 · Idacio (adalimumab or adalimumab-aacf) is an injectable medication belonging to a class called TNF blockers. It's used to treat many autoimmune conditions, including ulcerative colitis, …

Aug 5, 2025 · IDACIO is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. IDACIO can be used …

Idacio: Adalimumab belongs to the class of medications called biological response modifiers ("biologics") or TNF blockers (tumor necrosis factor blockers).